Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma

Author:

Chiba Tetsuhiro12,Saito Tomoko12,Yuki Kaori12,Zen Yoh3,Koide Shuhei2,Kanogawa Naoya1,Motoyama Tenyu1,Ogasawara Sadahisa1,Suzuki Eiichiro1,Ooka Yoshihiko1,Tawada Akinobu1,Otsuka Masayuki4,Miyazaki Masaru4,Iwama Atsushi2,Yokosuka Osamu1

Affiliation:

1. Department of Gastroenterology and Nephrology; Graduate School of Medicine, Chiba University; Chuo-ku Chiba Japan

2. Department of Cellular and Molecular Medicine; Graduate School of Medicine, Chiba University; Chuo-ku Chiba Japan

3. Histopathology Section; Institute of Liver Studies, King's College Hospital; Denmark Hill London United Kingdom

4. Department of General Surgery; Graduate School of Medicine, Chiba University; Inohana Chuo-ku Chiba Japan

Funder

Global COE Program (Global Center for Education and Research in Immune System Regulation and Treatment)

Ministry of Education, Culture, Sports, Science and Technology, Japan

Core Research for Evolutional Science and Technology (CREST)

Japan Science and Technology Corporation (JST)

Foundation for the Promotion of Cancer Research

Publisher

Wiley

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3